{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T06:15:54Z","timestamp":1787984154320,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Research Foundation of Kore","award":["RS-2025-23323176"],"award-info":[{"award-number":["RS-2025-23323176"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11604-026-02010-9","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T03:18:40Z","timestamp":1780111120000},"page":"1660-1670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of liver fibrosis on gadolinium retention from gadodiamide, gadobutrol, and gadoxetate disodium in rats"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1586-4819","authenticated-orcid":false,"given":"Hyung Cheol","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4985-8000","authenticated-orcid":false,"given":"Hyewon","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2899-9480","authenticated-orcid":false,"given":"Hye Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9025-6274","authenticated-orcid":false,"given":"Jin-Young","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0811-9578","authenticated-orcid":false,"given":"Yong Eun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"issue":"1","key":"2010_CR1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/RLI.0000000000000605","volume":"55","author":"E Lancelot","year":"2020","unstructured":"Lancelot E, Desch\u00e9 P. Gadolinium retention as a safety signal: experience of a manufacturer. Invest Radiol. 2020;55(1):20\u20134.","journal-title":"Invest Radiol"},{"issue":"2","key":"2010_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1148\/radiol.2018181151","volume":"289","author":"RJ McDonald","year":"2018","unstructured":"McDonald RJ, Levine D, Weinreb J, Kanal E, Davenport MS, Ellis JH, et al. Gadolinium retention: a research roadmap from the 2018 NIH\/ACR\/RSNA workshop on Gadolinium chelates. Radiology. 2018;289(2):517\u201334.","journal-title":"Radiology"},{"issue":"10","key":"2010_CR3","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/RLI.0000000000000507","volume":"53","author":"VM Runge","year":"2018","unstructured":"Runge VM. Dechelation (transmetalation): consequences and safety concerns with the linear Gadolinium-based contrast agents, in view of recent health care rulings by the EMA (Europe), FDA (United States), and PMDA (Japan). Invest Radiol. 2018;53(10):571\u20138.","journal-title":"Invest Radiol"},{"issue":"8","key":"2010_CR4","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1097\/RLI.0000000000000559","volume":"54","author":"G Jost","year":"2019","unstructured":"Jost G, Frenzel T, Boyken J, Schoeckel L, Pietsch H. Gadolinium presence in the brain after administration of the liver-specific Gadolinium-based contrast agent Gadoxetate: a systematic comparison to multipurpose agents in rats. Invest Radiol. 2019;54(8):468\u201374.","journal-title":"Invest Radiol"},{"key":"2010_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-020-02434-8","author":"CA Mallio","year":"2020","unstructured":"Mallio CA, Rovira \u00c0, Parizel PM, Quattrocchi CC. Exposure to gadolinium and neurotoxicity: current status of preclinical and clinical studies. Neuroradiology. 2020. https:\/\/doi.org\/10.1007\/s00234-020-02434-8.","journal-title":"Neuroradiology"},{"issue":"1","key":"2010_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1148\/radiology.183.1.1549695","volume":"183","author":"G Schuhmann-Giampieri","year":"1992","unstructured":"Schuhmann-Giampieri G, Schmitt-Willich H, Press WR, Negishi C, Weinmann HJ, Speck U. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology. 1992;183(1):59\u201364.","journal-title":"Radiology"},{"issue":"3","key":"2010_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00261-014-0227-5","volume":"40","author":"TA Hope","year":"2015","unstructured":"Hope TA, Fowler KJ, Sirlin CB, Costa EA, Yee J, Yeh BM, et al. Hepatobiliary agents and their role in LI-RADS. Abdom Imaging. 2015;40(3):613\u201325.","journal-title":"Abdom Imaging"},{"issue":"11","key":"2010_CR8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/01.rli.0000184756.66360.d3","volume":"40","author":"M Rohrer","year":"2005","unstructured":"Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann HJ. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol. 2005;40(11):715\u201324.","journal-title":"Invest Radiol"},{"issue":"7","key":"2010_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/RLI.0000000000000360","volume":"52","author":"S Ichikawa","year":"2017","unstructured":"Ichikawa S, Motosugi U, Omiya Y, Onishi H. Contrast agent-induced high signal intensity in dentate nucleus on unenhanced T1-weighted images: comparison of Gadodiamide and Gadoxetic Acid. Invest Radiol. 2017;52(7):389\u201395.","journal-title":"Invest Radiol"},{"key":"2010_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/mrm.28249","author":"H Oh","year":"2020","unstructured":"Oh H, Chung YE, You JS, Joo CG, Kim PK, Lim JS, et al. Gadolinium retention in rat abdominal organs after administration of gadoxetic acid disodium compared to gadodiamide and gadobutrol. Magn Reson Med. 2020. https:\/\/doi.org\/10.1002\/mrm.28249.","journal-title":"Magn Reson Med"},{"issue":"11","key":"2010_CR11","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1097\/RLI.0000000000000294","volume":"51","author":"Y Cao","year":"2016","unstructured":"Cao Y, Zhang Y, Shih G, Zhang Y, Bohmart A, Hecht EM, et al. Effect of renal function on Gadolinium-related signal increases on unenhanced T1-weighted brain magnetic resonance imaging. Invest Radiol. 2016;51(11):677\u201382.","journal-title":"Invest Radiol"},{"issue":"2","key":"2010_CR12","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1148\/radiol.2017161594","volume":"285","author":"RJ McDonald","year":"2017","unstructured":"McDonald RJ, McDonald JS, Dai D, Schroeder D, Jentoft ME, Murray DL, et al. Comparison of Gadolinium concentrations within multiple rat organs after intravenous administration of linear versus macrocyclic Gadolinium chelates. Radiology. 2017;285(2):536\u201345.","journal-title":"Radiology"},{"issue":"6","key":"2010_CR13","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1002\/mrm.28060","volume":"83","author":"NM Damme","year":"2020","unstructured":"Damme NM, Fernandez DP, Wang LM, Wu Q, Kirk RA, Towner RA, et al. Analysis of retention of gadolinium by brain, bone, and blood following linear gadolinium-based contrast agent administration in rats with experimental sepsis. Magn Reson Med. 2020;83(6):1930\u20139.","journal-title":"Magn Reson Med"},{"key":"2010_CR14","first-page":"3901907","volume":"2019","author":"S-t Wang","year":"2019","unstructured":"Wang S-t, Hua Z-x, Fan D-x, Zhang X, Ren K. Gadolinium retention and clearance in the diabetic brain after Administrations of Gadodiamide, Gadopentetate Dimeglumine, and Gadoterate Meglumine in a Rat Model. BioMed Res Int. 2019;2019:3901907.","journal-title":"BioMed Res Int"},{"key":"2010_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37\u201355.","journal-title":"Mol Aspects Med"},{"issue":"9","key":"2010_CR16","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1124\/dmd.107.020073","volume":"36","author":"K Nakai","year":"2008","unstructured":"Nakai K, Tanaka H, Hanada K, Ogata H, Suzuki F, Kumada H, et al. Decreased expression of cytochromes P450 1A2, 2E1, and 3A4 and drug transporters Na+-taurocholate-cotransporting polypeptide, organic cation transporter 1, and organic anion-transporting peptide-C correlates with the progression of liver fibrosis in chronic hepatitis C patients. Drug Metab Dispos. 2008;36(9):1786\u201393.","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"2010_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1148\/radiol.14140313","volume":"274","author":"M Lagadec","year":"2015","unstructured":"Lagadec M, Doblas S, Giraudeau C, Ronot M, Lambert SA, Fasseu M, et al. Advanced fibrosis: correlation between pharmacokinetic parameters at dynamic gadoxetate-enhanced MR imaging and hepatocyte organic anion transporter expression in rat liver. Radiology. 2015;274(2):379\u201386.","journal-title":"Radiology"},{"key":"2010_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27419","author":"P Wei","year":"2024","unstructured":"Wei P, Hu Q, He C, Hua P, Yang D, Shao C, et al. Gadolinium deposition in the liver and brain in a rat model with liver fibrosis after intravenous administration of gadoxetate disodium. Heliyon. 2024. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27419.","journal-title":"Heliyon"},{"issue":"1 Suppl","key":"2010_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41684-019-0450-3","volume":"49","author":"MC Wallace","year":"2015","unstructured":"Wallace MC, Hamesch K, Lunova M, Kim Y, Weiskirchen R, Strnad P, et al. Standard operating procedures in experimental liver research: thioacetamide model in mice and rats. Lab Anim. 2015;49(1 Suppl):21\u20139.","journal-title":"Lab Anim"},{"issue":"2","key":"2010_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27\u201331.","journal-title":"J Basic Clin Pharm"},{"issue":"2","key":"2010_CR21","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/hep.510240201","volume":"24","author":"P Bedossa","year":"1996","unstructured":"Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology. 1996;24(2):289\u201393 (The METAVIR Cooperative Study Group).","journal-title":"Hepatology"},{"key":"2010_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-025-01902-6","author":"J Seo","year":"2025","unstructured":"Seo J, Oh H, Park GB, Chung YE. Repeated gadolinium-based contrast agent exposure increases depression-like behavior in rats. Japn J Radiol. 2025. https:\/\/doi.org\/10.1007\/s11604-025-01902-6.","journal-title":"Japn J Radiol"},{"issue":"1","key":"2010_CR23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11604-015-0503-5","volume":"34","author":"T Kanda","year":"2016","unstructured":"Kanda T, Oba H, Toyoda K, Kitajima K, Furui S. Brain gadolinium deposition after administration of gadolinium-based contrast agents. Jpn J Radiol. 2016;34(1):3\u20139.","journal-title":"Jpn J Radiol"},{"issue":"12","key":"2010_CR24","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/RLI.0b013e3181852171","volume":"43","author":"T Frenzel","year":"2008","unstructured":"Frenzel T, Lengsfeld P, Schirmer H, Hutter J, Weinmann HJ. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Invest Radiol. 2008;43(12):817\u201328.","journal-title":"Invest Radiol"},{"issue":"3","key":"2010_CR25","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1148\/radiol.2017162857","volume":"285","author":"E Gianolio","year":"2017","unstructured":"Gianolio E, Bardini P, Arena F, Stefania R, Di Gregorio E, Iani R, et al. Gadolinium retention in the rat brain: assessment of the amounts of insoluble Gadolinium-containing species and intact Gadolinium complexes after repeated administration of Gadolinium-based contrast agents. Radiology. 2017;285(3):839\u201349.","journal-title":"Radiology"},{"issue":"2","key":"2010_CR26","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bpg.2011.02.005","volume":"25","author":"UE Lee","year":"2011","unstructured":"Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25(2):195\u2013206.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"8","key":"2010_CR27","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jacc.2010.11.013","volume":"57","author":"N Mewton","year":"2011","unstructured":"Mewton N, Liu CY, Croisille P, Bluemke D, Lima JAC. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol. 2011;57(8):891\u2013903.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2010_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5604\/16652681.1184191","volume":"15","author":"K Grungreiff","year":"2016","unstructured":"Grungreiff K, Reinhold D, Wedemeyer H. The role of zinc in liver cirrhosis. Ann Hepatol. 2016;15(1):7\u201316.","journal-title":"Ann Hepatol"},{"issue":"11","key":"2010_CR29","first-page":"20603","volume":"8","author":"M Kang","year":"2015","unstructured":"Kang M, Zhao L, Ren M, Deng M, Li C. Reduced metallothionein expression induced by zinc deficiency results in apoptosis in hepatic stellate cell line LX-2. Int J Clin Exp Med. 2015;8(11):20603\u20139.","journal-title":"Int J Clin Exp Med"},{"issue":"6","key":"2010_CR30","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1177\/0300985815588607","volume":"52","author":"S Sridharan","year":"2015","unstructured":"Sridharan S, Allen AL, Kidney B, Al-Dissi AN. Metallothionein expression in dogs with chronic hepatitis and its correlation with hepatic fibrosis, inflammation, and Ki-67 expression. Vet Pathol. 2015;52(6):1127\u201333.","journal-title":"Vet Pathol"},{"key":"2010_CR31","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0378-4274(99)00272-6","volume":"112\u2013113","author":"M Berglund","year":"2000","unstructured":"Berglund M, Akesson A, Bjellerup P, Vahter M. Metal-bone interactions. Toxicol Lett. 2000;112\u2013113:219\u201325.","journal-title":"Toxicol Lett"},{"issue":"5","key":"2010_CR32","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/jmri.27124","volume":"52","author":"M Rasschaert","year":"2020","unstructured":"Rasschaert M, Weller RO, Schroeder JA, Brochhausen C, Id\u00e9e JM. Retention of gadolinium in brain parenchyma: pathways for speciation, access, and distribution. A critical review. J Magn Reson Imaging. 2020;52(5):1293\u2013305.","journal-title":"J Magn Reson Imaging"},{"issue":"7","key":"2010_CR33","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.3174\/ajnr.A4615","volume":"37","author":"J Ramalho","year":"2016","unstructured":"Ramalho J, Semelka RC, Ramalho M, Nunes RH, AlObaidy M, Castillo M. Gadolinium-based contrast agent accumulation and toxicity: an update. AJNR Am J Neuroradiol. 2016;37(7):1192\u20138.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"11","key":"2010_CR34","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1111\/bcp.13718","volume":"84","author":"KA Layne","year":"2018","unstructured":"Layne KA, Dargan PI, Archer JR, Wood DM. Gadolinium deposition and the potential for toxicological sequelae\u2013a literature review of issues surrounding Gadolinium-based contrast agents. Br J Clin Pharmacol. 2018;84(11):2522\u201334.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"2010_CR35","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jhep.2020.04.011","volume":"73","author":"YA Nevzorova","year":"2020","unstructured":"Nevzorova YA, Boyer-Diaz Z, Cubero FJ, Gracia-Sancho J. Animal models for liver disease \u2013 a practical approach for translational research. J Hepatol. 2020;73(2):423\u201340.","journal-title":"J Hepatol"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-02010-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-026-02010-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-02010-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:17:34Z","timestamp":1787980654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-026-02010-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,30]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2010"],"URL":"https:\/\/doi.org\/10.1007\/s11604-026-02010-9","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,30]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no potential conflicts of interest to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}